It can be used to alleviate and improve early symptoms caused by chronic hepatitis B, such as fatigue, dizziness, loss of appetite, etc.; it is also indicated for symptoms during the progression of the disease, such as palmar erythema, spider angiomas, and enlargement of the liver and spleen. Fokam Pharmaceutical's tenofovir alafenamide fumarate has a CDE registration status of "I".